• Search

Search in Site

Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Posts tagged with»vascular surgery

NEXUS gets FDA approval: can Endospan finally crack the hardest segment in endovascular aortic repair?

By Pallavi Madhiraju on April 8, 2026   Medical Devices & Diagnostics  

NEXUS gets FDA approval: can Endospan finally crack the hardest segment in endovascular aortic repair?

Endospan’s FDA-approved NEXUS system could reshape high-risk aortic arch repair. Read what the approval changes and what clinicians will watch next.

CE Mark clearance for BD Revello stent highlights growing competition in endovascular PAD therapies

By Pallavi Madhiraju on March 8, 2026   Medical Devices & Diagnostics  

CE Mark clearance for BD Revello stent highlights growing competition in endovascular PAD therapies

BD secures EU CE Mark for the Revello vascular covered stent for iliac artery disease. Explore what this device could change for PAD treatment in Europe.

Profusa Lumee Oxygen gains pre-approval orders as EU MDR decision looms

By Soujanya Ravi on February 19, 2026   Medical Devices & Diagnostics  

Profusa Lumee Oxygen gains pre-approval orders as EU MDR decision looms

Profusa secures Lumee Oxygen orders ahead of EU MDR clearance. Discover what this means for CLTI monitoring and 2026 commercialization.

Why Philips LumiGuide could disrupt image-guided therapy with real-time light-based 3D navigation

By Srinath B on December 1, 2025   Medical Devices & Diagnostics  

Why Philips LumiGuide could disrupt image-guided therapy with real-time light-based 3D navigation

Philips expands LumiGuide AI 3D light-based navigation across US and Europe. Find out how it could reshape image-guided therapy without radiation.

Recent Posts

  • AACR 2026: SAGA Diagnostics pushes Pathlight MRD deeper into metastatic breast and ovarian cancer
  • Agenus AACR 2026 data show immune reprogramming signal in PD-1 refractory gastroesophageal cancer
  • AACR 2026: Can Zai Lab’s zocilurtatug pelitecan change the treatment picture for small cell lung cancer brain metastases?
  • How JANX014 expands Janux Therapeutics’ tumor-activated platform strategy in prostate cancer immunotherapy
  • What Medicus Pharma Ltd.’s SkinJect application signals for Hedgehog pathway-driven cancers
  • Why Bioxodes’ adaptive trial strategy could accelerate approval timelines in stroke therapeutics
  • What Kura Oncology’s latest data reveals about resistance biology in kidney cancer
  • Can Fate Therapeutics, Inc. solve the conditioning chemotherapy problem in CAR T?
  • Could Ampligen become a late-stage pancreatic cancer breakthrough after AIM ImmunoTech’s latest clinical push?
  • What the new J-code means for Glaukos’ Epioxa launch and the future of keratoconus reimbursement
  • Molgramostim review pushed to November: what Savara’s FDA delay means for autoimmune PAP
  • What SurGenTec’s TiLink navigation clearance means for surgeons using minimally invasive SI joint fusion systems
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes